Home › Federal Circuit Keeps Sandoz Biosimilar Off the Market for Now
 

Keywords :   


Federal Circuit Keeps Sandoz Biosimilar Off the Market for Now

2015-05-08 04:19:44| Biotech - Topix.net

The Federal Circuit is set to hear oral arguments in Amgen v. Sandoz on June 3, but in the meantime has granted Amgen's motion for a preliminary injunction to keep Sandoz' biosimilar version of Neupogen off the market until it renders its decision.

Tags: now market federal circuit

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.07Tropical Storm Beryl Public Advisory Number 36A
07.07Summary for Tropical Storm Beryl (AT2/AL022024)
07.07Atlantic Tropical Weather Outlook
07.07Eastern North Pacific Tropical Weather Outlook
07.07Tropical Storm Beryl Potential Storm Surge Flooding Map
07.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
07.07Tropical Storm Beryl Storm Surge Watch/Warning Map
07.07Tropical Storm Beryl Graphics
More »